ANTI-VIRAL AND INTERFERON-INDUCING ACTIVITIES OF A NEW PEPTIDOMANNAN, KS-2, EXTRACTED FROM CULTURE MYCELIA OF LENTINUS-EDODES

被引:30
作者
SUZUKI, F
SUZUKI, C
SHIMOMURA, E
MAEDA, H
FUJII, T
ISHIDA, N
机构
[1] KUMAMOTO UNIV, SCH MED, DEPT MICROBIOL, KUMAMOTO 860, JAPAN
[2] KIRIN BREWERY CO LTD, DEPT MED & PHARMACEUT DEV, SHIBUYA KU, TOKYO 150, JAPAN
关键词
D O I
10.7164/antibiotics.32.1336
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Oral (PO) administration of KS-2 to adult DDI mice resulted in a peak serum interferon (IF) titer of 800 units (U)/ml 20 hours after administration with detectable levels persisting until 30 hours. After intraperitoneal (IP) injection, a peak serum IF titer of 1,600 U/ml was detected and it followed the same time course as that of oral administration. The IF induced by KS-2 shared certain physico-chemical properties with the standard preparation of immune IF and was not neutralized by an antiserum against type I IF. In mice infected intranasally (IN) with influenza A2 (H2N2) virus, KS-2 was found to possess significant protective activities. Efficacy of the agent was evidenced by an increase in survivor number, a prolongation of mean survival time, an inhibition of the development of lung consolidation induced by the viral infection and a decrease in virus titer in lung tissues. Both PO and IP administrations of KS-2 protected mice against infection and significant antiviral activities were achieved not only by prophylactic but also chemotherapeutic administration. No virocidal or virostatic activities of KS-2 to the influenza virus were found in vitro. The protective activities of KS-2 against influenza virus infection in mice are discussed in view of the immunopotentiation of the host animals. © 1979, JAPAN ANTIBIOTICS RESEARCH ASSOCIATION. All rights reserved.
引用
收藏
页码:1336 / 1345
页数:10
相关论文
共 32 条
[1]   RESISTANCE OF FEMALE MICE TO VAGINAL INFECTION INDUCED BY HERPESVIRUS-HOMINIS TYPE 2 - EFFECTS OF IMMUNIZATION WITH MYCOBACTERIUM-BOVIS, INTRAVENOUS-INJECTION OF SPECIFIC HERPESVIRUS-HOMINIS TYPE 2 ANTISERUM, AND A COMBINATION OF THESE PROCEDURES [J].
BAKER, MB ;
LARSON, CL ;
USHIJIMA, RN ;
ANDERSON, FD .
INFECTION AND IMMUNITY, 1974, 10 (06) :1230-1234
[2]  
CHIHARA G, 1969, Nature (London), V222, P687
[3]  
DECLERCQ E, 1970, J CLIN INVEST, V49, P1565
[4]   ISOLATION AND CHARACTERIZATION OF A NEW ANTI-TUMOR POLYSACCHARIDE, KS-2, EXTRACTED FROM CULTURE MYCELIA OF LENTINUS-EDODES [J].
FUJII, T ;
MAEDA, H ;
SUZUKI, F ;
ISHIDA, N .
JOURNAL OF ANTIBIOTICS, 1978, 31 (11) :1079-1090
[5]   QUANTITATIVE ASPECTS OF THE MULTIPLICATION OF INFLUENZA-A VIRUS IN THE MOUSE LUNG - RELATION BETWEEN THE DEGREE OF VIRAL MULTIPLICATION AND THE EXTENT OF PNEUMONIA [J].
GINSBERG, HS ;
HORSFALL, FL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1952, 95 (02) :135-145
[6]   ROLE OF ENDOGENOUS INTERFERON IN ANTI-TUMOR EFFECT OF POLY I.C AND STATOLON AS DEMONSTRATED BY USE OF ANTI-MOUSE INTERFERON SERUM [J].
GRESSER, I ;
MAURY, C ;
BANDU, MT ;
TOVEY, M ;
MAUNOURY, MT .
INTERNATIONAL JOURNAL OF CANCER, 1978, 21 (01) :72-77
[7]   INDUCTION OF INTERFERON-PRODUCTION IN MOUSE SPLEEN-CELL CULTURES BY CORYNEBACTERIUM-PARVUM [J].
HIRT, HM ;
BECKER, H ;
KIRCHNER, H .
CELLULAR IMMUNOLOGY, 1978, 38 (01) :168-175
[8]  
ISHIDA NAKAO, 1959, TOHOKU JOUR EXPTL MED, V71, P151, DOI 10.1620/tjem.71.151
[10]   PRODUCTION OF AN ANTIVIRAL FACTOR BY MURINE SPLEEN-CELLS AFTER TREATMENT WITH CORYNEBACTERIUM-PARVUM [J].
KIRCHNER, H ;
HIRT, HM ;
BECKER, H ;
MUNK, K .
CELLULAR IMMUNOLOGY, 1977, 31 (01) :172-176